Estradiol gel

Review of the pharmacology, pharmacokinetics, efficacy, and safety in menopausal women

Mark Naunton, Asmar F.Y. Al Hadithy, Jacobus R.B.J. Brouwers, David F. Archer

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

OBJECTIVE: To review the pharmacology, pharmacokinetics, safety, and efficacy of a gel containing estradiol that is applied to the skin. DESIGN: MEDLINE and EMBASE searches were conducted from 1966 to March 2005. Additional references were identified from bibliographies from selected studies in addition to approved product information. RESULTS: Estradiol gel is indicated for the relief of moderate to severe vasomotor symptoms in menopausal women, and moderate to severe symptoms of vulvar and vaginal atrophy. Women who are intolerant of the oral route, have had previous hypersensitivity skin reactions, or have had difficulties with adhesive patches are ideal candidates for estradiol gel. CONCLUSIONS: Estradiol gel can effectively reduce menopause symptoms with minimal side effects. Long-term safety data of estradiol gel are required.

Original languageEnglish
Pages (from-to)517-527
Number of pages11
JournalMenopause
Volume13
Issue number3
DOIs
Publication statusPublished - 1 May 2006
Externally publishedYes

Fingerprint

Estradiol
Pharmacokinetics
Gels
Pharmacology
Safety
Skin
Bibliography
Menopause
MEDLINE
Adhesives
Atrophy
Hypersensitivity

Cite this

Naunton, Mark ; Al Hadithy, Asmar F.Y. ; Brouwers, Jacobus R.B.J. ; Archer, David F. / Estradiol gel : Review of the pharmacology, pharmacokinetics, efficacy, and safety in menopausal women. In: Menopause. 2006 ; Vol. 13, No. 3. pp. 517-527.
@article{959e692c3ec94006a847e53ffd14e08d,
title = "Estradiol gel: Review of the pharmacology, pharmacokinetics, efficacy, and safety in menopausal women",
abstract = "OBJECTIVE: To review the pharmacology, pharmacokinetics, safety, and efficacy of a gel containing estradiol that is applied to the skin. DESIGN: MEDLINE and EMBASE searches were conducted from 1966 to March 2005. Additional references were identified from bibliographies from selected studies in addition to approved product information. RESULTS: Estradiol gel is indicated for the relief of moderate to severe vasomotor symptoms in menopausal women, and moderate to severe symptoms of vulvar and vaginal atrophy. Women who are intolerant of the oral route, have had previous hypersensitivity skin reactions, or have had difficulties with adhesive patches are ideal candidates for estradiol gel. CONCLUSIONS: Estradiol gel can effectively reduce menopause symptoms with minimal side effects. Long-term safety data of estradiol gel are required.",
keywords = "Estradiol gel, Menopause, Percutaneous, Transdermal, Vaginal atrophy, Vasomotor symptoms",
author = "Mark Naunton and {Al Hadithy}, {Asmar F.Y.} and Brouwers, {Jacobus R.B.J.} and Archer, {David F.}",
year = "2006",
month = "5",
day = "1",
doi = "10.1097/01.gme.0000191881.52175.8c",
language = "English",
volume = "13",
pages = "517--527",
journal = "Menopause",
issn = "1072-3714",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

Estradiol gel : Review of the pharmacology, pharmacokinetics, efficacy, and safety in menopausal women. / Naunton, Mark; Al Hadithy, Asmar F.Y.; Brouwers, Jacobus R.B.J.; Archer, David F.

In: Menopause, Vol. 13, No. 3, 01.05.2006, p. 517-527.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Estradiol gel

T2 - Review of the pharmacology, pharmacokinetics, efficacy, and safety in menopausal women

AU - Naunton, Mark

AU - Al Hadithy, Asmar F.Y.

AU - Brouwers, Jacobus R.B.J.

AU - Archer, David F.

PY - 2006/5/1

Y1 - 2006/5/1

N2 - OBJECTIVE: To review the pharmacology, pharmacokinetics, safety, and efficacy of a gel containing estradiol that is applied to the skin. DESIGN: MEDLINE and EMBASE searches were conducted from 1966 to March 2005. Additional references were identified from bibliographies from selected studies in addition to approved product information. RESULTS: Estradiol gel is indicated for the relief of moderate to severe vasomotor symptoms in menopausal women, and moderate to severe symptoms of vulvar and vaginal atrophy. Women who are intolerant of the oral route, have had previous hypersensitivity skin reactions, or have had difficulties with adhesive patches are ideal candidates for estradiol gel. CONCLUSIONS: Estradiol gel can effectively reduce menopause symptoms with minimal side effects. Long-term safety data of estradiol gel are required.

AB - OBJECTIVE: To review the pharmacology, pharmacokinetics, safety, and efficacy of a gel containing estradiol that is applied to the skin. DESIGN: MEDLINE and EMBASE searches were conducted from 1966 to March 2005. Additional references were identified from bibliographies from selected studies in addition to approved product information. RESULTS: Estradiol gel is indicated for the relief of moderate to severe vasomotor symptoms in menopausal women, and moderate to severe symptoms of vulvar and vaginal atrophy. Women who are intolerant of the oral route, have had previous hypersensitivity skin reactions, or have had difficulties with adhesive patches are ideal candidates for estradiol gel. CONCLUSIONS: Estradiol gel can effectively reduce menopause symptoms with minimal side effects. Long-term safety data of estradiol gel are required.

KW - Estradiol gel

KW - Menopause

KW - Percutaneous

KW - Transdermal

KW - Vaginal atrophy

KW - Vasomotor symptoms

UR - http://www.scopus.com/inward/record.url?scp=33745234078&partnerID=8YFLogxK

U2 - 10.1097/01.gme.0000191881.52175.8c

DO - 10.1097/01.gme.0000191881.52175.8c

M3 - Review article

VL - 13

SP - 517

EP - 527

JO - Menopause

JF - Menopause

SN - 1072-3714

IS - 3

ER -